Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2010
05/27/2010US20100129364 Combination therapy for the treatment of ocular neovascular disorders
05/27/2010US20100129363 Methods and compositions using pde4 inhibitors for the treatment and management of cancers
05/27/2010US20100129362 Treatment of psoriatic arthritis with anti-cd70 antibody
05/27/2010US20100129361 Immunosuppression with antibody against itm2a
05/27/2010US20100129360 Antibodies against human interleukin-13 and uses therefor
05/27/2010US20100129359 Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers
05/27/2010US20100129358 Method of detecting ocular diseases and pathologic conditions and treatment of same
05/27/2010US20100129357 Antibodies to il-6 and use thereof
05/27/2010US20100129356 Compositions and methods for modulating vascular development
05/27/2010US20100129355 Therapeutic agents for ocular inflammatory disease comprising interleukin 6 receptor inhibitor as active ingredient
05/27/2010US20100129354 Intranasal delivery of polypeptides and proteins
05/27/2010US20100129353 Combination and treatment for multiple sclerosis
05/27/2010US20100129352 Novel pharmaceutical composition
05/27/2010US20100129351 Compositions and Methods for Altering Pancreas or Liver Function
05/27/2010US20100129350 Triazine Derivatives, Compositions Containing Such Derivatives, and Methods of Treatment of Cancer and Autoimmune Diseases Using Such Derivatives
05/27/2010US20100129349 Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus
05/27/2010US20100129348 Method for decreasing depression by inhibiting the activity of alpha 1b subunit of n-type calcium channel
05/27/2010US20100129347 Herpes virus infection inhibitor, method for inhibiting infection with herpes virus, and use thereof
05/27/2010US20100129346 Anti-C5aR Antibodies With Improved Properties
05/27/2010US20100129345 Screening method for prokinetic agent
05/27/2010US20100129344 Medical uses and therapies based upon the action of azurocidin on igfbp-1
05/27/2010US20100129320 Quinoline derivatives for modulating dna methylation
05/27/2010US20100129315 Anti-MN Antibodies and Methods of Using Same
05/27/2010US20100129314 Potent conjugates and hydrophilic linkers
05/27/2010US20100129313 Kidney-specific tumor vaccine directed against kidney tumor antigen g-250
05/27/2010CA2781591A1 Implantable liposome embedded matrix composition, uses thereof, and polycaprolactone praticles as scaffolds for tissue regeneration
05/27/2010CA2781197A1 Hiv/siv vaccines for the generation of mucosal and systemic immunity
05/27/2010CA2744348A1 Recombinant inactivated viral vector vaccine
05/27/2010CA2744339A1 Method for treating parkinson's disease
05/27/2010CA2744326A1 Tcl1 as a transcriptional regulator
05/27/2010CA2744251A1 Salmonella marker vaccine
05/27/2010CA2744158A1 Anti-angiogenesis therapy for the treatment of breast cancer
05/27/2010CA2744048A1 Single-time vaccines
05/27/2010CA2743950A1 Peptide conjugates for suppressing an immune response, methods of making and uses therefor
05/27/2010CA2743508A1 C-met antibodies
05/27/2010CA2743229A1 Priming of an immune response
05/27/2010CA2743012A1 Rsv f vlps and methods of manufacture and use thereof
05/27/2010CA2737045A1 Therapeutic protein formulations
05/26/2010EP2189919A1 Method and system for building a phylogeny from genetic sequences and using the same for recommendation of vaccine strain candidates for the influenza virus
05/26/2010EP2189526A1 Antibody binding specifically to tdp-43 aggregate
05/26/2010EP2189473A2 Nucleic and proteins from streptococcus groups A & B
05/26/2010EP2189471A1 Foxm1 peptide and medicinal agent comprising the same
05/26/2010EP2189470A1 Tumor antigens
05/26/2010EP2189166A1 Methods and materials for treating and diagnosing kallikrein-6 related inflammatory conditions
05/26/2010EP2189165A1 Capsular polysaccharide solubilisation and combination vaccines
05/26/2010EP2189164A1 Salmonella marker vaccine
05/26/2010EP2189162A1 Methods for the treatment of cellular proliferative disorders
05/26/2010EP2189156A1 Lys-Pro and Lys-Pro-Thr for the manufacture of a cosmetic composition
05/26/2010EP2188313A1 Human c-fms antigen binding proteins
05/26/2010EP2188310A1 Humanized anti-fgf19 antagonists and methods using same
05/26/2010EP2188304A1 Detection and quantitation of urine gelsolin
05/26/2010EP2187965A1 Psma binding ligand-linker conjugates and methods for using
05/26/2010EP2187964A1 High affinity human antibodies to human nerve growth factor
05/26/2010EP2187963A1 Imageable rodent model of asthma
05/26/2010EP2187960A1 Compositions and methods for microbe storage and delivery
05/26/2010EP2187959A2 Diagnostic method and kit
05/26/2010EP2187958A1 Attenuated ehrlichiosis vaccine
05/26/2010EP2187743A2 Formulations for treatment of ocular diseases or conditions
05/26/2010EP1718737B1 Cancerous disease modifying antibodies
05/26/2010EP1613345B1 Compositions and methods involving respiratory syncytial virus subgroup b strain 9320
05/26/2010EP1605971B1 Immunogenic composition and methods
05/26/2010EP1596809B1 Abeta binding molecules
05/26/2010EP1448602B1 Modified anti-tnf alpha antibody
05/26/2010EP1370275B1 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside
05/26/2010EP1307225B1 Antagonists of cd30 or cd30l for use in treating auto-immune and chronic inflammatory conditions
05/26/2010EP1272665B1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
05/26/2010EP1144642B1 Compounds and methods for treatment and diagnosis of chlamydial infection
05/26/2010EP1037916B1 Erythrovirus and its applications
05/26/2010CN1984656B Cancer treatment method
05/26/2010CN1961961B A pharmaceutical formulation and preparation process thereof
05/26/2010CN1912111B Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen
05/26/2010CN1880457B Ad6 recombinant nucleic acid
05/26/2010CN1838967B Stabilized immunogenic HBc chimer particles
05/26/2010CN1833027B Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
05/26/2010CN1829796B Novel full-length genomic RNA of Japanese encephalitis virus, infectious JEV cDNA therefrom, and use thereof
05/26/2010CN1814301B Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
05/26/2010CN1791433B DNA vaccines against tumor growth and methods of use thereof
05/26/2010CN1758899B Dosage form having a saccharide matrix
05/26/2010CN1756763B Dimerized peptide
05/26/2010CN1751064B Hsp60 from arthrobacter
05/26/2010CN1746298B Artificial recombinant H7 subinfluenza virus and use thereof
05/26/2010CN1741815B 疟疾疫苗 Malaria Vaccine
05/26/2010CN1711282B Inhibition of Il-17 production
05/26/2010CN1678744B Human antihuman interleukin-6 antibody and fragment of the antibody
05/26/2010CN1671412B Immunostimulatory compositions and methods of stimulating an immune response
05/26/2010CN1671407B Compositions and methods for treating diabetes
05/26/2010CN1668637B Molecular antigen arrays using a virus like particle derived from the AP205 coat protein
05/26/2010CN1665933B Immunoconjugates for the treatment of tumours
05/26/2010CN1638807B Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
05/26/2010CN1596313B Humanized collagen antibodies and related methods
05/26/2010CN1578678B Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
05/26/2010CN1518458B Graft rejection inhibitors
05/26/2010CN1468308B Anti-TNF antibodies, compositions, methods and uses
05/26/2010CN1425066B Novel stra6 polypeptides
05/26/2010CN101715456A Milk derived antigen specific antibodies, methods of preparation and uses thereof
05/26/2010CN101715348A A new immunoglobulin against helicobacter pylori
05/26/2010CN101712965A Japanese encephalitis virus JEV replicon vector and application thereof
05/26/2010CN101712960A Mac-2BP tumor antigen gene, protein, antibody and application thereof
05/26/2010CN101712949A Gm-negative ehv-mutants without heterologous elements
05/26/2010CN101712935A Candida albicans toxicity related gene CaMSS11 and application thereof
1 ... 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 ... 1823